PNC Financial Services Group Inc. Purchases 26,705 Shares of SPDR S&P Biotech ETF $XBI

PNC Financial Services Group Inc. lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 60.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 70,527 shares of the exchange traded fund’s stock after acquiring an additional 26,705 shares during the period. PNC Financial Services Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $7,067,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. JPMorgan Chase & Co. grew its stake in SPDR S&P Biotech ETF by 2.6% during the second quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock worth $882,218,000 after purchasing an additional 268,399 shares during the period. Bessemer Group Inc. lifted its stake in SPDR S&P Biotech ETF by 9.3% in the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock valued at $163,624,000 after buying an additional 138,322 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares in the last quarter. Meitav Investment House Ltd. grew its position in shares of SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after buying an additional 281,602 shares during the period. Finally, Greenhouse Funds LLLP grew its position in shares of SPDR S&P Biotech ETF by 17.3% during the 2nd quarter. Greenhouse Funds LLLP now owns 579,667 shares of the exchange traded fund’s stock worth $48,072,000 after buying an additional 85,422 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.9%

SPDR S&P Biotech ETF stock opened at $126.74 on Friday. The company has a market capitalization of $8.47 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $132.09. The firm’s fifty day moving average is $124.62 and its 200 day moving average is $110.82.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.